BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel M, Chen J, Kim S, Garg S, Flannery B, Haddadin Z, Rankin D, Halasa N, Talbot HK, Reed C. Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States. Emerg Infect Dis 2020;26:1720-30. [PMID: 32348234 DOI: 10.3201/eid2608.191493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Myint PK, Carter B, Barlow-Pay F, Short R, Einarsson AG, Bruce E, McCarthy K, Verduri A, Collins J, Hesford J, Rickard F, Mitchell E, Holloway M, McGovern A, Vilches-Moraga A, Braude P, Pearce L, Stechman M, Price A, Quinn TJ, Clini E, Moug S, Hewitt J. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19. Ther Adv Drug Saf 2021;12:2042098620985690. [PMID: 33680426 DOI: 10.1177/2042098620985690] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hughes K, Middleton DB, Nowalk MP, Balasubramani GK, Martin ET, Gaglani M, Talbot HK, Patel MM, Ferdinands JM, Zimmerman RK, Silveira FP; HAIVEN Study Investigators. Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults. Clin Infect Dis 2021:ciaa1927. [PMID: 33388741 DOI: 10.1093/cid/ciaa1927] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Tenforde MW, Patel MM, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Gaglani M, McNeal T, Ghamande S, Shapiro NI, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Exline MC, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CT, Busse L, Lohuis CCT, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Gershengorn HB, Babcock HM, Kwon JH, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Lindsell CJ, Hart KW, Zhu Y, Olson SM, Stephenson M, Schrag SJ, Kobayashi M, Verani JR, Self WH; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. medRxiv 2021:2021. [PMID: 34268515 DOI: 10.1101/2021.07.08.21259776] [Cited by in Crossref: 9] [Article Influence: 9.0] [Reference Citation Analysis]
4 Embi PJ, Levy ME, Naleway AL, Patel P, Gaglani M, Natarajan K, Dascomb K, Ong TC, Klein NP, Liao IC, Grannis SJ, Han J, Stenehjem E, Dunne MM, Lewis N, Irving SA, Rao S, McEvoy C, Bozio CH, Murthy K, Dixon BE, Grisel N, Yang DH, Goddard K, Kharbanda AB, Reynolds S, Raiyani C, Fadel WF, Arndorfer J, Rowley EA, Fireman B, Ferdinands J, Valvi NR, Ball SW, Zerbo O, Griggs EP, Mitchell PK, Porter RM, Kiduko SA, Blanton L, Zhuang Y, Steffens A, Reese SE, Olson N, Williams J, Dickerson M, McMorrow M, Schrag SJ, Verani JR, Fry AM, Azziz-Baumgartner E, Barron MA, Thompson MG, DeSilva MB. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep 2021;70:1553-9. [PMID: 34735426 DOI: 10.15585/mmwr.mm7044e3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Patel MM, York IA, Monto AS, Thompson MG, Fry AM. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. The Lancet Microbe 2021;2:e715-25. [DOI: 10.1016/s2666-5247(21)00180-4] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Di Fusco M, Moran MM, Cane A, Curcio D, Khan F, Malhotra D, Surinach A, Miles A, Swerdlow D, McLaughlin JM, Nguyen JL. Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2. J Med Econ 2021;24:1248-60. [PMID: 34844493 DOI: 10.1080/13696998.2021.2002063] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Embi PJ, Levy ME, Naleway AL, Patel P, Gaglani M, Natarajan K, Dascomb K, Ong TC, Klein NP, Liao IC, Grannis SJ, Han J, Stenehjem E, Dunne MM, Lewis N, Irving SA, Rao S, McEvoy C, Bozio CH, Murthy K, Dixon BE, Grisel N, Yang DH, Goddard K, Kharbanda AB, Reynolds S, Raiyani C, Fadel WF, Arndorfer J, Rowley EA, Fireman B, Ferdinands J, Valvi NR, Ball SW, Zerbo O, Griggs EP, Mitchell PK, Porter RM, Kiduko SA, Blanton L, Zhuang Y, Steffens A, Reese SE, Olson N, Williams J, Dickerson M, McMorrow M, Schrag SJ, Verani JR, Fry AM, Azziz-Baumgartner E, Barron MA, Thompson MG, DeSilva MB. Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021. Am J Transplant 2022;22:306-14. [PMID: 34967121 DOI: 10.1111/ajt.16641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Carnino L, Schwob JM, Neofytos D, Lazo-Porras M, Chappuis F, Eperon G. Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational Study. Trop Med Infect Dis 2021;6:170. [PMID: 34564554 DOI: 10.3390/tropicalmed6030170] [Reference Citation Analysis]
9 Tritle BJ, Hejazi AA, Timbrook TT. The effectiveness and safety of low dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis pneumonia: A systematic review and meta-analysis. Transpl Infect Dis 2021;23:e13737. [PMID: 34553814 DOI: 10.1111/tid.13737] [Reference Citation Analysis]
10 Barber MS, Barrett R, Bradley RD, Walker E. A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review. Complement Ther Med 2021;63:102788. [PMID: 34748955 DOI: 10.1016/j.ctim.2021.102788] [Reference Citation Analysis]
11 Doolub G, Kobo O, Mohamed MO, Ullah W, Chadi Alraies M, Velagapudi P, Matula JS, Roguin A, Bagur R, Mamas MA. Outcomes of Percutaneous Coronary Intervention in Patients With Acquired Immunosuppression. Am J Cardiol 2022;171:40-8. [PMID: 35303973 DOI: 10.1016/j.amjcard.2022.01.045] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Barlow-Pay F, Htut TW, Khezrian M, Myint PK. Systematic review of immunosuppressant guidelines in the COVID-19 pandemic. Ther Adv Drug Saf 2021;12:2042098620985687. [PMID: 33628418 DOI: 10.1177/2042098620985687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Pasman R, Krom BP, Zaat SAJ, Brul S. The Role of the Oral Immune System in Oropharyngeal Candidiasis-Facilitated Invasion and Dissemination of Staphylococcus aureus. Front Oral Health 2022;3:851786. [DOI: 10.3389/froh.2022.851786] [Reference Citation Analysis]